// App-Quantinova.ai

: Dermatologic Adverse Events in Acute Lymphocytic Leukemia Patients Treated with Bispecific T-Cell Engager Blinatumomab

Researchers

Presenter

  • Rose Parisi

Principal Investigators

  • Emily A Cowen

  • Stephanie Gu

  • Melissa Pulitzer

  • Mark B. Geyer

  • Amber C. King

  • Alina Markova

Medical Centers

  • Department of Pathology, Memorial Sloan Kettering Cancer Center, NEW YORK, NY

  • ALBANY MEDICAL COLLEGE, Albany, NY

  • Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

  • Memorial Sloan Kettering Cancer Center, New York

  • Department of Dermatology, Weill Cornell Medical College, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

  • Dermatology

Disease

  • Acute lymphoblastic leukemia

  • Cytokine release syndrome

  • Seborrheic dermatitis

  • Psoriasis

  • Atopic Dermatitis

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

  • Acne

Biomarkers

  • Ph chromosome

  • Apparent diffusion coefficient

  • Twist-related protein 1

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved